154 related articles for article (PubMed ID: 30458696)
21. The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.
Azar I; Al Masalmeh N; Esfandiarifard S; Virk G; Kiwan W; Frank Shields A; Mehdi S; Philip PA
Cancer Med; 2021 May; 10(9):2987-2995. PubMed ID: 33797856
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
Lemmens VE; van Halteren AH; Janssen-Heijnen ML; Vreugdenhil G; Repelaer van Driel OJ; Coebergh JW
Ann Oncol; 2005 May; 16(5):767-72. PubMed ID: 15817594
[TBL] [Abstract][Full Text] [Related]
23. Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population-based study.
Feller A; Schmidlin K; Bordoni A; Bouchardy C; Bulliard JL; Camey B; Konzelmann I; Maspoli M; Wanner M; Zwahlen M; Clough-Gorr KM;
Cancer Med; 2018 Apr; 7(4):1498-1510. PubMed ID: 29479854
[TBL] [Abstract][Full Text] [Related]
24. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
[TBL] [Abstract][Full Text] [Related]
25. Patterns of Care for Metastatic Colorectal Cancer in Appalachia, and the Clinical, Sociodemographic, and Service Provider Determinants.
Fleming ST; Mackley HB; Camacho F; Yao N; Gusani NJ; Seiber EE; Matthews SA; Yang TC; Hwang W
J Rural Health; 2016; 32(2):113-24. PubMed ID: 26241785
[TBL] [Abstract][Full Text] [Related]
26. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project.
Storm HH; Engholm G; Pritzkuleit R; Kejs AM; Katalinic A; Dunst J; Holländer NH
Eur J Cancer; 2015 Jun; 51(9):1188-98. PubMed ID: 25483784
[TBL] [Abstract][Full Text] [Related]
27. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
[TBL] [Abstract][Full Text] [Related]
28. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.
Gulack BC; Nussbaum DP; Keenan JE; Ganapathi AM; Sun Z; Worni M; Migaly J; Mantyh CR
Dis Colon Rectum; 2016 Apr; 59(4):299-305. PubMed ID: 26953988
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study.
Kim TJ; Kim ER; Hong SN; Chang DK; Kim YH
Medicine (Baltimore); 2016 May; 95(19):e3641. PubMed ID: 27175682
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
Larsen MB; Njor S; Ingeholm P; Andersen B
Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.
Williams DS; Mouradov D; Browne C; Palmieri M; Elliott MJ; Nightingale R; Fang CG; Li R; Mariadason JM; Faragher I; Jones IT; Churilov L; Tebbutt NC; Gibbs P; Sieber OM
Mod Pathol; 2020 Mar; 33(3):483-495. PubMed ID: 31471586
[TBL] [Abstract][Full Text] [Related]
33. The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system.
Steele SR; Park GE; Johnson EK; Martin MJ; Stojadinovic A; Maykel JA; Causey MW
Dis Colon Rectum; 2014 Mar; 57(3):303-10. PubMed ID: 24509451
[TBL] [Abstract][Full Text] [Related]
34. Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany.
Lamberti C; Di Blasi K; Archut D; Fimmers R; Mathiak M; Bollmann M; Vogel J; Kindermann D; Mezger J; Schmidt-Wolf IG; Sauerbruch T
Z Gastroenterol; 2005 Feb; 43(2):149-54. PubMed ID: 15700204
[TBL] [Abstract][Full Text] [Related]
35. SURVIVAL OF PATIENTS WITH COLORECTAL CANCER IN A CANCER CENTER.
Aguiar Junior S; Oliveira MM; Silva DRME; Mello CAL; Calsavara VF; Curado MP
Arq Gastroenterol; 2020; 57(2):172-177. PubMed ID: 33206858
[TBL] [Abstract][Full Text] [Related]
36. Do the Oncological and Surgical Outcomes of Young and Older Women Differ in the Treatment of Colorectal Cancer?
Han EC; Park JW; Kwon YH; Song I; Kim JS; Ryoo SB; Jeong SY; Park KJ
J Womens Health (Larchmt); 2019 Feb; 28(2):258-267. PubMed ID: 30481101
[TBL] [Abstract][Full Text] [Related]
37. Racial differences in the outcome of patients with colorectal carcinoma.
Govindarajan R; Shah RV; Erkman LG; Hutchins LF
Cancer; 2003 Jan; 97(2):493-8. PubMed ID: 12518374
[TBL] [Abstract][Full Text] [Related]
38. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
[TBL] [Abstract][Full Text] [Related]
39. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
[TBL] [Abstract][Full Text] [Related]
40. Long-term Outcomes of One Stage Surgery Using Transanal Colorectal Tube for Acute Colorectal Obstruction of Stage II/III Distal Colon Cancer.
Okuda Y; Yamada T; Hirata Y; Shimura T; Yamaguchi R; Sakamoto E; Sobue S; Nakazawa T; Kataoka H; Joh T
Cancer Res Treat; 2019 Apr; 51(2):474-482. PubMed ID: 29879759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
